Squarepoint Portfolio holdings
AUM
$45.5B
1-Year Return
6.73%
This Quarter Return
+5.44%
1 Year Return
+6.73%
3 Year Return
+22.51%
5 Year Return
+41.07%
10 Year Return
+76.91%
AUM
$45.5B
AUM Growth
+$4.5B
(+11%)
Cap. Flow
+$397M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
23.46%
Holding
3,358
New
566
Increased
1,087
Reduced
1,014
Closed
583
Top Buys
| 1 |
Amazon
AMZN
|
+$454M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$333M |
| 3 |
Eli Lilly
LLY
|
+$293M |
| 4 |
Costco
COST
|
+$290M |
| 5 |
Ford
F
|
+$274M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.7B |
| 2 |
Apple
AAPL
|
+$374M |
| 3 |
Carrier Global
CARR
|
+$193M |
| 4 |
Fair Isaac
FICO
|
+$191M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$190M |
Sector Composition
| 1 | Technology | 22.49% |
| 2 | Consumer Discretionary | 14.95% |
| 3 | Financials | 10.21% |
| 4 | Healthcare | 10% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAFX
2626
XCF Global, Inc. Class A Common Stock
SAFX
$197M
| $38.4K | ﹤0.01% |
+21,797
| New | +$38.4K |
|
2627
Taboola.com
TBLA
$1.01B
| $37.8K | ﹤0.01% |
10,329
-156,821
| -94% | -$574K |
|
2628
Assertio
ASRT
$77.5M
| $37.6K | ﹤0.01% |
58,657
-183,603
| -76% | -$118K |
|
2629
Caribou Biosciences
CRBU
$178M
| $37.5K | ﹤0.01% |
+29,729
| New | +$37.5K |
|
2630
Lantronix
LTRX
$179M
| $36.2K | ﹤0.01% |
+12,629
| New | +$36.2K |
|
2631
PLAYSTUDIOS Inc
MYPS
$120M
| $35.7K | ﹤0.01% |
27,244
+3,171
| +13% | +$4.15K |
|
2632
SELLAS Life Sciences
SLS
$199M
| $35.3K | ﹤0.01% |
+16,122
| New | +$35.3K |
|
2633
American Rebel
AREB
$5.63M
| $35K | ﹤0.01% |
+27,744
| New | +$35K |
|
2634
OPAL Fuels
OPAL
$64.4M
| $33.2K | ﹤0.01% |
13,713
-83,592
| -86% | -$202K |
|
2635
Pulmonx
LUNG
$68.9M
| $33K | ﹤0.01% |
12,742
+1,062
| +9% | +$2.75K |
|
|
GCTS
2636
GCT Semiconductor Holding
GCTS
$85.5M
| $32.9K | ﹤0.01% |
+22,076
| New | +$32.9K |
|
2637
TScan Therapeutics
TCRX
$105M
| $32.6K | ﹤0.01% |
+22,497
| New | +$32.6K |
|
2638
Fathom Holdings
FTHM
$79.9M
| $31.6K | ﹤0.01% |
25,462
-67,812
| -73% | -$84.1K |
|
|
AUTL
2639
Autolus Therapeutics
AUTL
$381M
| $30.8K | ﹤0.01% |
+13,507
| New | +$30.8K |
|
2640
AmpliTech
AMPG
$78.6M
| $30.6K | ﹤0.01% |
14,439
-3,968
| -22% | -$8.41K |
|
2641
Achieve Life Sciences
ACHV
$161M
| $30.4K | ﹤0.01% |
+13,437
| New | +$30.4K |
|
2642
Coherus Oncology, Inc. Common Stock
CHRS
$155M
| $30K | ﹤0.01% |
+41,058
| New | +$30K |
|
2643
Holley
HLLY
$372M
| $29.9K | ﹤0.01% |
+14,950
| New | +$29.9K |
|
2644
Heartbeam
BEAT
$48.7M
| $29.7K | ﹤0.01% |
+23,798
| New | +$29.7K |
|
2645
OmniAb
OABI
$230M
| $28.8K | ﹤0.01% |
16,541
+1,702
| +11% | +$2.96K |
|
2646
Invivyd
IVVD
$258M
| $26.7K | ﹤0.01% |
+37,323
| New | +$26.7K |
|
2647
GoPro
GPRO
$316M
| $26.7K | ﹤0.01% |
+35,231
| New | +$26.7K |
|
2648
Fossil Group
FOSL
$167M
| $26.2K | ﹤0.01% |
17,715
+400
| +2% | +$592 |
|
2649
AC Immune
ACIU
$239M
| $25.7K | ﹤0.01% |
12,642
-9,764
| -44% | -$19.8K |
|
2650
Castellum
CTM
$103M
| $25.1K | ﹤0.01% |
+23,940
| New | +$25.1K |
|